Combined Modality Therapy of Localized Gastric and Esophageal Cancers

Authors: Prajnan Das MD, MS, MPH a , Norio Fukami MD a and Jaffer A. Ajani MD a
View More View Less
  • a From the Department of Radiation Oncology, the Department of Gastrointestinal Medicine and Nutrition, and the Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas.

Gastric and esophageal cancers continue to be a significant health problem. The incidence of proximal gastric and distal esophageal cancers has been increasing, especially in white men. Gastric and esophageal cancers have high rates of locoregional and distant failure, resulting in poor overall survival. Therefore, patients with gastric and esophageal cancer may benefit from combined modality therapy. Adjuvant chemoradiation has been shown to improve survival in gastric and gastroesophageal cancers in a phase III trial. In esophageal cancer, most randomized trials have not shown a survival benefit for preoperative chemotherapy or chemoradiation, although these approaches are widely used. This article reviews the role of staging, surgery, and adjuvant and preoperative therapies in the management of localized gastric and esophageal cancers.

If the inline PDF is not rendering correctly, you can download the PDF file here.

Correspondence: Prajnan Das, Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 97, Houston, TX 77030. E-mail: PrajDas@mdanderson.org
  • 1.

    Jemal A, Murray T, Ward E. Cancer statistics, 2005. CA Cancer J Clin 2005;55:1030.

  • 2.

    Parkin DM, Bray F, Ferlay J. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74108.

  • 3.

    Posner MC, Forastiere AA, Minsky BD. Cancer of the esophagus. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology, 7th ed. Philadelphia: Lippincott; 2005: 861909.

    • Search Google Scholar
    • Export Citation
  • 4.

    Pisters PWT, Kelsen DP, Powell SM. Cancer of the stomach. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology; 7th ed. Philadelphia: Lippincott; 2005: 909944.

    • Search Google Scholar
    • Export Citation
  • 5.

    Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:20492053.

    • Search Google Scholar
    • Export Citation
  • 6.

    Botet JF, Lightdale CJ, Zauber AG. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 1991;181:419425.

    • Search Google Scholar
    • Export Citation
  • 7.

    Ziegler K, Sanft C, Zimmer T. Comparison of computed tomography, endosonography, and intraoperative assessment in TN staging of gastric carcinoma. Gut 1993;34:604610.

    • Search Google Scholar
    • Export Citation
  • 8.

    Lightdale CJ, Kulkarni KG. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 2005;23:44834489.

    • Search Google Scholar
    • Export Citation
  • 9.

    Dittler HJ, Siewert JR. Role of endoscopic ultrasonography in gastric carcinoma. Endoscopy 1993;25:162166.

  • 10.

    Murata Y, Suzuki S, Ohta M. Small ultrasonic probes for determination of the depth of superficial esophageal cancer. Gastrointest Endosc 1996;44:2328.

    • Search Google Scholar
    • Export Citation
  • 11.

    Hasegawa N, Niwa Y, Arisawa T. Preoperative staging of superficial esophageal carcinoma: comparison of an ultrasound probe and standard endoscopic ultrasonography. Gastrointest Endosc 1996;44:388393.

    • Search Google Scholar
    • Export Citation
  • 12.

    Kato H, Miyazaki T, Nakajima M. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 2005;103:148156.

    • Search Google Scholar
    • Export Citation
  • 13.

    Kole AC, Plukker JT, Nieweg OE. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998;78:521527.

    • Search Google Scholar
    • Export Citation
  • 14.

    Swisher SG, Maish M, Erasmus JJ. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 2004;78:11521160.

    • Search Google Scholar
    • Export Citation
  • 15.

    Kim SK, Kang KW, Lee JS. Assessment of lymph node metastases using (18)F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006;33:148155.

    • Search Google Scholar
    • Export Citation
  • 16.

    Chen J, Cheong JH, Yun MJ. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer 2005;103:23832390.

    • Search Google Scholar
    • Export Citation
  • 17.

    Metzger R, Bollschweiler E, Vallbohmer D. High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 2004;17:310314.

    • Search Google Scholar
    • Export Citation
  • 18.

    Birkmeyer NJ, Goodney PP, Stukel TA. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 2005;103:435441.

    • Search Google Scholar
    • Export Citation
  • 19.

    Maruyama K, Gunven P, Okabayashi K. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 1989;210:596602.

  • 20.

    Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005;23: 71147124.

    • Search Google Scholar
    • Export Citation
  • 21.

    Bonenkamp JJ, Hermans J, Sasako M. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999;340:908914.

    • Search Google Scholar
    • Export Citation
  • 22.

    Cuschieri A, Weeden S, Fielding J. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999;79:15221530.

    • Search Google Scholar
    • Export Citation
  • 23.

    American Joint Committee on Cancer. AJCC Cancer Staging Handbook, 6th ed. New York: Springer Verlag; 2002.

  • 24.

    Hulscher JB, van Sandick JW, de Boer AG. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002;347: 16621669.

    • Search Google Scholar
    • Export Citation
  • 25.

    Avital S, Zundel N, Szomstein S. Laparoscopic transhiatal esophagectomy for esophageal cancer. Am J Surg 2005;190:6974.

  • 26.

    de Hoyos A, Litle VR, Luketich JD. Minimally invasive esophagectomy. Surg Clin North Am 2005;85:631647.

  • 27.

    Soetikno R, Kaltenbach T, Yeh R. Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol 2005;23:44904498.

    • Search Google Scholar
    • Export Citation
  • 28.

    Landry J, Tepper JE, Wood WC. Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Oncol Biol Phys 1990;19:13571362.

    • Search Google Scholar
    • Export Citation
  • 29.

    Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1982;8:111.

    • Search Google Scholar
    • Export Citation
  • 30.

    Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 1999;35:10591064.

    • Search Google Scholar
    • Export Citation
  • 31.

    Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 2002;168: 597608.

  • 32.

    Hermans J, Bonenkamp JJ, Boon MC. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993;11:14411447.

    • Search Google Scholar
    • Export Citation
  • 33.

    Mari E, Floriani I, Tinazzi A. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000;11:837843.

    • Search Google Scholar
    • Export Citation
  • 34.

    Panzini I, Gianni L, Fattori PP. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 2002;88:2127.

    • Search Google Scholar
    • Export Citation
  • 35.

    Macdonald JS, Smalley SR, Benedetti J. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345: 725730.

    • Search Google Scholar
    • Export Citation
  • 36.

    Hundahl SA, Macdonald JS, Benedetti J. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002;9:278286.

    • Search Google Scholar
    • Export Citation
  • 37.

    Smalley SR, Gunderson L, Tepper J. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys 2002;52:283293.

    • Search Google Scholar
    • Export Citation
  • 38.

    Meyerhardt JA, Fuchs CS. Adjuvant therapy in gastric cancer: can we prevent recurrences? Oncology (Williston Park) 2003;17: 714721, 728.

  • 39.

    Cunningham D, Allum WH, Stenning SP. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: final results of a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). J Clin Oncol 2005;23[suppl]:308s.

    • Search Google Scholar
    • Export Citation
  • 40.

    Ajani JA, Mansfield PF, Janjan N. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol 2004;22:27742780.

    • Search Google Scholar
    • Export Citation
  • 41.

    Ajani JA, Mansfield PF, Crane CH. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol 2005;23:12371244.

    • Search Google Scholar
    • Export Citation
  • 42.

    Okawara GS, Winter K, Donohue JH. A phase II trial of preoperative chemotherapy and chemoradiotherapy for potentially resectable adenocarcinoma of the stomach (RTOG 99-04). J Clin Oncol 2005;23[suppl]:312s.

    • Search Google Scholar
    • Export Citation
  • 43.

    Moertel CG, Childs DS Jr, Reitemeier RJ. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet 1969;2:865867.

    • Search Google Scholar
    • Export Citation
  • 44.

    Le Chevalier T, Smith FP, Harter WK. Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma. Semin Oncol 1985;12:4653.

    • Search Google Scholar
    • Export Citation
  • 45.

    Gunderson LL, Hoskins RB, Cohen AC. Combined modality treatment of gastric cancer. Int J Radiat Oncol Biol Phys 1983;9: 965975.

  • 46.

    Henning GT, Schild SE, Stafford SL. Results of irradiation or chemoirradiation for primary unresectable, locally recurrent, or grossly incomplete resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys 2000;46:109118.

    • Search Google Scholar
    • Export Citation
  • 47.

    Kelsen DP, Ginsberg R, Pajak TF. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:19791984.

    • Search Google Scholar
    • Export Citation
  • 48.

    Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002; 359:17271733.

    • Search Google Scholar
    • Export Citation
  • 49.

    Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2002;183:274279.

    • Search Google Scholar
    • Export Citation
  • 50.

    Malthaner RA, Wong RK, Rumble RB. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med 2004;2:35.

    • Search Google Scholar
    • Export Citation
  • 51.

    Walsh TN, Noonan N, Hollywood D. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462467.

    • Search Google Scholar
    • Export Citation
  • 52.

    Bosset JF, Gignoux M, Triboulet JP. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161167.

    • Search Google Scholar
    • Export Citation
  • 53.

    Urba SG, Orringer MB, Turrisi A. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305313.

    • Search Google Scholar
    • Export Citation
  • 54.

    Burmeister BH, Smithers BM, Gebski V. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005;6:659668.

    • Search Google Scholar
    • Export Citation
  • 55.

    Lee JL, Park SI, Kim SB. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004;15:947954.

    • Search Google Scholar
    • Export Citation
  • 56.

    Krasna M, Tepper JE, Niedzwiecki D. Trimodality therapy is superior to surgery alone in esophageal cancer: results of CALGB 9781. Proc 2006 GI Cancers Symp 2006:86, Abstr 4.

    • Search Google Scholar
    • Export Citation
  • 57.

    Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185:538543.

    • Search Google Scholar
    • Export Citation
  • 58.

    Herskovic A, Martz K, al-Sarraf M. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326:15931598.

    • Search Google Scholar
    • Export Citation
  • 59.

    Cooper JS, Guo MD, Herskovic A. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281:16231627.

    • Search Google Scholar
    • Export Citation
  • 60.

    Wong R, Malthaner R. Combined chemotherapy and radiotherapy (without surgery) compared with radiotherapy alone in localized carcinoma of the esophagus. Cochrane Database Syst Rev 2006: CD002092.

    • Search Google Scholar
    • Export Citation
  • 61.

    Minsky BD, Pajak TF, Ginsberg RJ. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:11671174.

    • Search Google Scholar
    • Export Citation
  • 62.

    Stahl M, Stuschke M, Lehmann N. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23: 23102317.

    • Search Google Scholar
    • Export Citation
  • 63.

    Bedenne L, Michel P, Bouche O. Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102) [abstract]. Proc Am Soc Clin Oncol 2002;21:130a.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 81 39 2
PDF Downloads 25 19 0
EPUB Downloads 0 0 0